Molecular analysis for diagnosing onychomycosis - PiedRéseau Rosemont
PiedRéseau Rosemont offers a specialized service in molecular analysis for diagnosing onychomycosis, a common superficial fungal infection affecting the nails. This advanced diagnostic tool allows our healthcare professionals to accurately identify the specific type of fungus present in a nail sample. By utilizing cutting-edge molecular techniques, we can detect over 50 different fungal species simultaneously, ensuring a precise diagnosis that informs effective treatment options.
The molecular analysis service plays a crucial role in the organization of patient care at our clinic. It enables our podiatrists to differentiate onychomycosis from other similar conditions, streamlining the diagnostic process. With results typically available within seven days, patients benefit from a quicker turnaround time compared to traditional diagnostic methods, which can take weeks. This efficiency supports timely and appropriate treatment interventions.
Our molecular analysis service is particularly beneficial for patients experiencing mixed infections, which can complicate treatment strategies. By identifying multiple infectious agents from a single sample, our podiatrists can tailor their approach, enhancing the likelihood of successful outcomes and minimizing the risk of recurrence.
The PiedRéseau Rosemont team is composed of dedicated professionals, including Dr. Constance Ladouceur Deslauriers, podiatrist-owner; Dr. Ann-Lyse Sanon, podiatrist; Dr. Salomé Archambault Boisvert, podiatrist; Mustapha Ouadah, bachelor nurse in foot care; Michèle Minomo Mayet, nurse assistant in foot care; Martin Couture, medical assistant; and Imane Harrak, medical assistant. Together, they ensure comprehensive care for all patients seeking treatment for onychomycosis and other foot-related concerns.